280 related articles for article (PubMed ID: 20568411)
1. [Management of patients with systemic sclerosis].
Wiesik-Szewczyk E; Olesińska M
Pol Merkur Lekarski; 2010 May; 28(167):421-3. PubMed ID: 20568411
[TBL] [Abstract][Full Text] [Related]
2. Management of systemic sclerosis.
Lim IG; Schrieber L
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):953-7. PubMed ID: 12455189
[No Abstract] [Full Text] [Related]
3. Treatment of systemic sclerosis.
Pope JE
Rheum Dis Clin North Am; 1996 Nov; 22(4):893-907. PubMed ID: 8923602
[TBL] [Abstract][Full Text] [Related]
4. Treatment Algorithms for Systemic Sclerosis According to Experts.
Fernández-Codina A; Walker KM; Pope JE;
Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
7. Scleroderma and related disorders: therapeutic aspects.
Denton CP; Black CM
Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
[TBL] [Abstract][Full Text] [Related]
8. Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O; Fransen J; Avouac J; Becker M; Kulak A; Allanore Y; Distler O; Clements P; Cutolo M; Czirjak L; Damjanov N; Del Galdo F; Denton CP; Distler JHW; Foeldvari I; Figelstone K; Frerix M; Furst DE; Guiducci S; Hunzelmann N; Khanna D; Matucci-Cerinic M; Herrick AL; van den Hoogen F; van Laar JM; Riemekasten G; Silver R; Smith V; Sulli A; Tarner I; Tyndall A; Welling J; Wigley F; Valentini G; Walker UA; Zulian F; Müller-Ladner U;
Ann Rheum Dis; 2017 Aug; 76(8):1327-1339. PubMed ID: 27941129
[TBL] [Abstract][Full Text] [Related]
9. Advances in the diagnosis and management of scleroderma-related vascular complications.
Kerin K; Yost JH
Compr Ther; 1998; 24(11-12):574-81. PubMed ID: 9847974
[TBL] [Abstract][Full Text] [Related]
10. [Systemic sclerosis].
Tamborrini G; Distler M; Distler O
Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
[TBL] [Abstract][Full Text] [Related]
11. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.
Nagaraja V; Matucci-Cerinic M; Furst DE; Kuwana M; Allanore Y; Denton CP; Raghu G; Mclaughlin V; Rao PS; Seibold JR; Pauling JD; Whitfield ML; Khanna D
Arthritis Rheumatol; 2020 Jul; 72(7):1049-1058. PubMed ID: 32134199
[TBL] [Abstract][Full Text] [Related]
12. [Lung involvement in systemic sclerosis].
Posa M; Stelle M; Lador F; Chizzolini C
Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
[TBL] [Abstract][Full Text] [Related]
13. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment].
Zuber JP; Chizzolini C; Leimgruber A; Bart PA; Spertini F
Rev Med Suisse; 2006 Apr; 2(62):1058, 1060-6. PubMed ID: 16711151
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.
Opitz C; Klein-Weigel PF; Riemekasten G
Vasa; 2011 Jan; 40(1):20-30. PubMed ID: 21283970
[TBL] [Abstract][Full Text] [Related]
15. Vascular disease in systemic sclerosis.
Poredos P
Vasa; 2011 Jan; 40(1):3-4. PubMed ID: 21375075
[No Abstract] [Full Text] [Related]
16. [Treatment of scleroderma].
Mouthon L
Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis: an update.
Varga J
Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632
[TBL] [Abstract][Full Text] [Related]
18. Current treatment options in systemic Sclerosis (Scleroderma).
Stummvoll GH
Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
[TBL] [Abstract][Full Text] [Related]
19. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study.
Rubio-Rivas M; Corbella X; Pestaña-Fernández M; Tolosa-Vilella C; Guillen-Del Castillo A; Colunga-Argüelles D; Trapiella-Martínez L; Iniesta-Arandia N; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas-Hitos JA; Ríos-Blanco JJ; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Segovia-Alonso P; Pla-Salas X; Madroñero-Vuelta AB; Ruiz-Muñoz M; Fonollosa-Pla V; Simeón-Aznar CP; ; Callejas Moraga E; Calvo E; Carbonell C; Castillo MJ; Chamorro AJ; Colunga D; Corbella X; Egurbide MV; Espinosa G; Fonollosa V; Freire M; García Hernández FJ; González León R; Guillén Del Castillo A; Iniesta N; Lorenzo R; Madroñero AB; Marí B; Marín A; Ortego-Centeno N; Pérez Conesa M; Pestaña M; Pla X; Ríos Blanco JJ; Rodríguez Carballeira M; Rubio Rivas M; Ruiz Muñoz M; Sáez Comet L; Segovia P; Simeón CP; Soto A; Tarí E; Todolí JA; Tolosa C; Trapiella L; Vargas Hitos JA; Verdejo G
Clin Rheumatol; 2018 Apr; 37(4):999-1009. PubMed ID: 29214548
[TBL] [Abstract][Full Text] [Related]
20. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]